About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Holy Cross 9th Annual Winter Oncology Symposium
https://www.hconcologysymposium.com/
9th Annual Winter Oncology Symposium
Lung Cancers
Gastrointestinal Cancers
Gyn Cancers
Breast Cancers
Events
Emerging Targets in HER-2 Negative, TNBC and HER-3 Positive Breast Cancer
By
Holy Cross 9th Annual Winter Oncology Symposium
FEATURING
Maysa Abu-Khalaf
April 23, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:54
Novartis Oncology
NCCN Category 1 Update: An Expert’s Perspective on First-Line Treatm…
Feat.
J. Cohen
Featured Video
22:25
Novartis Oncology
The Importance of Dosing and Patient Adherence in HR+/HER2- mBC
Feat.
N. McAndrew
Breast Cancers
24:03
Holy Cross 9th Annual Winter Oncology Symposium
Early Stage Breast Cancer - Comparison of Trials of Genomic Assays -…
Feat.
R. L. Mahtani
14:23
Holy Cross 9th Annual Winter Oncology Symposium
Oncoplastic Reduction in Locally Advanced Breast Cancer
Feat.
J. Burgers
13:07
Holy Cross 9th Annual Winter Oncology Symposium
Panel Discussion on Breast Cancer: Promising Drugs and Future Treatm…
Feat.
E. Segota,
R. L. Mahtani,
J. Burgers,
M. Abu-Khalaf,
B. Moy
24:33
Holy Cross 9th Annual Winter Oncology Symposium
Therapeutic Strategies in HER2+ Breast Cancer - Pertuzumab, Neratini…
Feat.
B. Moy
12:05
Holy Cross 9th Annual Winter Oncology Symposium
Future Directions in the Targeting of HER2+ Breast Cancer: duration …
Feat.
B. Moy
12:44
Holy Cross 9th Annual Winter Oncology Symposium
Emerging Targets in ER Positive Breast Cancer: CDK4/6 inhibitors, Bc…
Feat.
M. Abu-Khalaf
10:12
Holy Cross 9th Annual Winter Oncology Symposium
Emerging Targets in HER-2 Negative, TNBC and HER-3 Positive Breast C…
Feat.
M. Abu-Khalaf
